(19)
(11) EP 3 471 628 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
21.04.2021 Bulletin 2021/16

(45) Mention of the grant of the patent:
17.03.2021 Bulletin 2021/11

(21) Application number: 17816054.5

(22) Date of filing: 20.06.2017
(51) International Patent Classification (IPC): 
A61B 17/00(2006.01)
A61B 17/068(2006.01)
A61B 17/32(2006.01)
 A61B 17/04(2006.01)
A61B 17/22(2006.01)
A61B 17/34(2006.01)
(86) International application number:
PCT/US2017/038309
(87) International publication number:
WO 2017/223073 (28.12.2017 Gazette 2017/52)

(54)

TRANSAPICAL REMOVAL DEVICE

TRANSAPIKALE ENTFERNUNGSVORRICHTUNG

DISPOSITIF DE RETRAIT TRANSAPICAL

(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 20.06.2016 US 201662352235 P

(43) Date of publication of application:
24.04.2019 Bulletin 2019/17

(60) Divisional application:
21161291.6

(73) Proprietor: Evalve, Inc.
Santa Clara, CA 95054 (US)

(72) Inventor:
  • DE MARCHENA, Eduardo M. D.
    Miami, FL 33156 (US)

(74) Representative: Studio Torta S.p.A. 
Via Viotti, 9
10121 Torino
10121 Torino (IT)


(56) References cited: : 
US-A1- 2006 074 484
US-A1- 2009 082 857
US-A1- 2015 257 883
 US-A1- 2008 140 189
US-A1- 2015 238 729
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).